How do senescent cells contribute to degenerative diseases, cancer, and immuno-senescence?
Senescence is a central hallmark of aging. Telomere damage, epigenetic dysregulation, DNA damage and.
The Judge Jeanine Tunnel to Towers Foundation Sunday Morning ShowJudge Jeanine talks about Trump’s indictment and Jim Jordan’s hearings, she invites two great guests to discuss our health and our military in this country. Tune in now!
Press release content from PR Newswire. The AP news staff was not involved in its creation.
Celularity and GX Acquisition Corp. Announce Merger Agreement to Create a Publicly Listed Leader in Allogeneic Cellular Therapy
January 8, 2021 GMT
FLORHAM PARK, N.J. and NEW YORK, Jan. 8, 2021 /PRNewswire/ Celularity Inc. (“Celularity”), a clinical-stage biotechnology company, leading the next evolution in cellular medicine with the development of off-the-shelf allogeneic therapies derived from the postpartum human placenta, and GX Acquisition Corp. (Nasdaq: GXGX), a special purpose acquisition company, today announced they have entered into a definitive merger agreement pursuant to which GX Acquisition Corp. will combine with Celularity. Upon the closing of the transaction, which is expected to occur in the second quarter of 2021, GX Acquisition Corp. will be renamed Celularity Inc., and its common stock and warrants are expected to remain listed on Nasdaq under the new ticker symbo